Guidelines of the French Society of ENT (SFORL): Drug-induced sleep endoscopy in adult obstructive sleep apnea syndrome

Eur Ann Otorhinolaryngol Head Neck Dis. 2022 Aug;139(4):216-225. doi: 10.1016/j.anorl.2022.05.003. Epub 2022 Jul 22.

Abstract

Objectives: To determine the indications, anesthesiological and surgical procedure and interest of drug-induced sleep endoscopy in the treatment of adult obstructive sleep apnea syndrome.

Design: A redactional committee of 17 experts was set up. Conflicts of interest were disclosed and followed up throughout the process of drawing up the guidelines. The work received no funding from any firm dealing in health products (drugs or devices). The GRADE (Grading of Recommendations Assessment, Development and Evaluation) method was applied to assess the quality of the data on which the guidelines were founded. It was stressed that strong recommendations should not be made on the basis of poor-quality or insufficient data.

Methods: The committee studied 29 questions on 5 topics: indications and contraindications, anesthetic technique, surgical technique, interpretation and reporting of results, and management guided by results.

Results: Expert review and application of the GRADE method led to 30 guidelines: 10 with high level of evidence (Grade 1+ or 1-), 19 with low level (GRADE 2+ or 2-) and 1 expert opinion.

Conclusion: Experts fully agreed on the strong guidelines formalizing the indications and modalities of drug-induced sleep endoscopy for adult obstructive sleep apnea syndrome.

Keywords: Airway surgery; DISE; Drug-induced sleep endoscopy; Mandibular Advancement Device; OSAS; Obstructive phenotypes; Obstructive sleep apneas syndrome; Palatal collapse; Propofol.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Endoscopy / methods
  • Humans
  • Nose
  • Sleep
  • Sleep Apnea, Obstructive* / diagnosis
  • Sleep Apnea, Obstructive* / surgery